Back to results
US 8,410,059 B2Granted
CXCR4 antagonist and use thereof
AssigneeBiokine Therapeutics Ltd.
InventorsNobutaka Fujii, Hirokazu Tamamura, Akira Hori
Life of this patent
Estimating the term…
Abstract
Therapeutic drugs for cancer and chronic rheumatoid arthritis which contain a peptide having a CXCR4 antagonism, its amide, its ester or its salt are described. Also, the present invention provides a novel peptide having a CXCR4 antagonism, its amide, its ester and its salt.
Claims3
The peptide 4F-benzoyl-Arg-Arg-NaI-Cys-Tyr-Cit-Lys-DLys-Pro-Try-Arg-Cit-Cys-Arg-NH2, or salt thereof.
Dependencies are inferred from the claim text.